Use of non-mammalian alternative models for neurotoxicological study
about
Alternatives to animal testing: A reviewFreshwater Planarians as an Alternative Animal Model for NeurotoxicologyThe C. elegans model in toxicity testingZebrafish as a model for acetylcholinesterase-inhibiting organophosphorus agent exposure and oxime reactivationApplication of a mathematical model to describe the effects of chlorpyrifos on Caenorhabditis elegans developmentCaenorhabditis elegans generates biologically relevant levels of genotoxic metabolites from aflatoxin B1 but not benzo[a]pyrene in vivoThe glutaredoxin GLRX-21 functions to prevent selenium-induced oxidative stress in Caenorhabditis elegansGene-environment interactions: neurodegeneration in non-mammals and mammalsZebrafish as a new model for phenotype-based screening of positive inotropic agents.A discrete time model for the analysis of medium-throughput C. elegans growth dataHigh-throughput screening and small animal models, where are we?Genetic aspects of behavioral neurotoxicologyIn vivo observation of gold nanoparticles in the central nervous system of Blaberus discoidalis.Exposure to Mn/Zn ethylene-bis-dithiocarbamate and glyphosate pesticides leads to neurodegeneration in Caenorhabditis elegansAssaying environmental nickel toxicity using model nematodes.Differential toxicity of carbon nanomaterials in Drosophila: larval dietary uptake is benign, but adult exposure causes locomotor impairment and mortality.Exposure to glyphosate- and/or Mn/Zn-ethylene-bis-dithiocarbamate-containing pesticides leads to degeneration of γ-aminobutyric acid and dopamine neurons in Caenorhabditis elegans.Organotellurium and organoselenium compounds attenuate Mn-induced toxicity in Caenorhabditis elegans by preventing oxidative stress.A microfluidic device for whole-animal drug screening using electrophysiological measures in the nematode C. elegans.Copper Oxide Nanoparticles Impact Several Toxicological Endpoints and Cause Neurodegeneration in Caenorhabditis elegans.Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology.Developmental neurotoxicity of pyrethroid insecticides in zebrafish embryosAdvancing toxicology research using in vivo high throughput toxicology with small fish models.The Caenorhabiditis elegans model as a reliable tool in neurotoxicology.Insights from Caenorhabditis elegans on the role of metals in neurodegenerative diseases.Zebrafish as a systems toxicology model for developmental neurotoxicity testing.Toxicity testing of neurotoxic pesticides in Caenorhabditis elegans.Exposure to Concentrated Ambient PM2.5 Shortens Lifespan and Induces Inflammation-Associated Signaling and Oxidative Stress in Drosophila.In vivo translocation and toxicity of multi-walled carbon nanotubes are regulated by microRNAs.Differential acetylcholinesterase inhibition of chlorpyrifos, diazinon and parathion in larval zebrafish.Alkyl Protocatechuate-Loaded Nanostructured Lipid Systems as a Treatment Strategy for Paracoccidioides brasiliensis and Paracoccidioides lutzii In VitroThe effects of triclosan on pluripotency factors and development of mouse embryonic stem cells and zebrafish.β-cypermethrin-induced acute neurotoxicity in the cerebral cortex of mice.Attenuation of γ-aminobutyric acid (GABA) transaminase activity contributes to GABA increase in the cerebral cortex of mice exposed to β-cypermethrin.Metabolic profiling in Caenorhabditis elegans provides an unbiased approach to investigations of dosage dependent lead toxicity.Evaluation of zebrafish brain development using optical coherence tomography.A novel lenticular arena to quantify locomotor competence in walking fruit flies.C. elegans as a model in developmental neurotoxicology.De novo transcriptome assembly of the lobster cockroach Nauphoeta cinerea (Blaberidae)In vivo reversal of general anesthesia by cucurbit[7]uril with zebrafish models
P2860
Q26852143-B4A33C59-2577-4846-BA49-9591A20CF973Q27319602-3528C9B8-34ED-415E-A78D-64339566ECCAQ28071970-6318CF1B-DDE2-4D14-83D7-E408766A780DQ28383839-E14554CB-8FF4-4A27-AB18-0A0BDFFD9A36Q28476134-CD226F5C-C4A4-493F-B730-72D9B9EB403FQ28748299-4F7504C4-62BB-4268-9CCB-80395F7BCC15Q28748302-FDB7F563-9B41-4F3F-80E2-1812C8CE58E9Q28750043-BEF4A796-9714-458B-8AD8-C38D1ECAAEFFQ31170242-9C29F6A9-AB2B-4EAE-94E5-1C72CF6B9EC6Q33503257-4252069A-6575-4ED4-8C2E-ED599676008EQ33566144-CEBA58CD-CFCE-4007-9C37-03CCA5DD09C5Q33863714-25871094-AC74-415E-A08D-E069CD906AD0Q34633399-B95E88B4-4570-4978-95B3-691508F0952FQ34881586-FEC23D75-1BCE-4217-B37A-F9EE6A1326CBQ35015054-8D944BB0-96C0-4703-BD29-C9A44BA7D3AEQ35138333-99B57576-823C-4D5A-BEA8-8078524D9342Q35785033-34D74EB8-BDC6-4205-A62A-FFC99E8C8E6FQ35926030-8DDA871D-EB7C-4490-80CD-B6D5CE6A3F9DQ36022803-2AC3C8E5-66FD-4C7C-BD09-03A0EB1327CBQ36212000-73DDFC2D-2C3E-40F7-BD5F-AEA20BEA83BFQ36927018-732A6603-8E09-4FFA-BC3B-982A5F2A986AQ37478125-7FE9858E-7F9E-410F-8296-4AF2F35BDE86Q37610145-1C22B66A-BB0C-48D0-BD76-EBAB2E981955Q37819497-568C8CF6-D3BB-4AA8-8575-1CB299C43665Q37826364-BF821758-1E8D-4152-ACE4-83EAB4DB31BEQ38238589-7C0D2BC1-8C94-4296-880C-3AA15B6010ABQ38247760-5C0AD1B2-F5F5-48D5-AF79-B037E1B14BE4Q39030452-D64717F4-CB9D-458A-9DE6-7EF4319F91F4Q39234619-F2DBFD34-1A83-4072-89C9-BE8A5ADD4842Q39425809-4347FC70-6FBD-414A-B14E-8557D0F1D018Q41940101-529B5275-6833-4662-BCA3-EBB5EF92FAC5Q42705494-66E1FA31-1839-46E2-B71D-C463B310A8A7Q42706304-4DBD9386-FC69-47E4-97D2-883584FC0D5CQ42708454-B063A371-2953-46C0-94AF-7B729F66B306Q42787856-6CB0738A-4662-44AD-834A-82A0427FB87FQ44950953-02FF46EC-A776-415F-8A40-26A3A4DBF746Q45057355-97730723-99CB-4C61-8330-6FB99BD62695Q52650568-4EDA10B8-41BA-4D8E-90FC-6F29544E3A30Q57178140-79067EB9-BF52-42F7-B5F3-FE86AEAA805FQ57618035-B4F91982-2B43-405E-8E16-5509E52BE93D
P2860
Use of non-mammalian alternative models for neurotoxicological study
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Use of non-mammalian alternative models for neurotoxicological study
@en
Use of non-mammalian alternative models for neurotoxicological study.
@nl
type
label
Use of non-mammalian alternative models for neurotoxicological study
@en
Use of non-mammalian alternative models for neurotoxicological study.
@nl
prefLabel
Use of non-mammalian alternative models for neurotoxicological study
@en
Use of non-mammalian alternative models for neurotoxicological study.
@nl
P2093
P2860
P1433
P1476
Use of non-mammalian alternative models for neurotoxicological study
@en
P2093
Jonathan H Freedman
Randall T Peterson
Richard Nass
Toshio Narahashi
P2860
P304
P356
10.1016/J.NEURO.2008.04.006
P577
2008-04-25T00:00:00Z